1. V. P. Zherdev, G. B. Kolyvanov, and A. A. Litvin, Farmateka, No. 3, 66 (2003).
2. Note for Guidance on the Investigation of Bioavailability and Bioequivalence, European Agency for the Evaluation of Medicinal Products, London, CPMP / EWP / 1401 / 98:18 (2001).
3. V. L. Bagirova, G. S. Kiseleva, and A. I. Tentsova, Farmateka, No. 1, 39–40 (1997).
4. The United States Pharmacopoeia 26th revision (2003).
5. Guidance for Industry: Immediate Release Solid Oral Dosage Forms. Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, in Vivo Dissolution Testing, and in Vivo Bioequivalence Documentation, Center for Drug Evaluation and Research (CDER) (1995).